dshah
★★  

India/United Kingdom,
2021-03-02 17:19
(1174 d 18:02 ago)

Posting: # 22238
Views: 2,477
 

 Bioanalysis monitoring by sponsor [Bioanalytics]

Greetings All!
Generally sponsors does monitoring for clinical phase, but up to how much extent sponsor can monitor ongoing bioanalysis? As per WHO- QA of CRO can decide up to which extent the data can be shared during ongoing analysis, but can sponsor completely monitor the bioanalysis?
In my opinion, sponsor shall not monitor the BA phase as they can influence the analysis and ultimately the study outcome. They may assign thir party for monitoring of BA phase.
Regards,
Dshah
Ohlbe
★★★

France,
2021-03-04 19:24
(1172 d 15:57 ago)

@ dshah
Posting: # 22243
Views: 1,942
 

 Bioanalysis monitoring by sponsor

Dear Dshah,

The bioanalytical part of the study is just as important as the clinical part and should deserve just as much QC and QA efforts from the sponsor as the clinical part. Therefore having the sponsor monitor or audit bioanalysis is, in itself, not a problem and I would actually encourage a better sponsor oversight.

What could be discussed is whether the monitoring or audit could take place in-process or only once activities are completed. However if you have processes in place with robust SOPs and stick to them, and make clear to the sponsor representatives in advance that they shall not try and influence in any way e.g. the acceptance of analytical runs or the re-analysis of certain samples, but only check compliance with GCP, GLP and your SOPs, it should be feasible. Still, I would recommend never to leave the sponsor representative alone with junior staff and to ensure there is always somebody there with enough authority to resist undue sponsor pressure.

Regards
Ohlbe
dshah
★★  

India/United Kingdom,
2021-03-06 05:32
(1171 d 05:50 ago)

@ Ohlbe
Posting: # 22249
Views: 1,932
 

 Bioanalysis monitoring by sponsor

Dear Ohlbe!
Actually I am from sponsor side. I agree for oversight or even the review of run that has completed, but shall sponsor monitor on going BA runs?

❝ make clear to the sponsor representatives in advance that they shall not try and influence in any way


So shall CRO share their SOP and then sponsor shall make agenda?
Thank you for your guidance.
Regards,
Dshah
Ohlbe
★★★

France,
2021-03-09 00:12
(1168 d 11:10 ago)

@ dshah
Posting: # 22251
Views: 1,852
 

 Bioanalysis monitoring by sponsor

Dear Dshah,

❝ […] shall sponsor monitor on going BA runs?


Up to you. It is neither made mandatory, nor forbidden by any guideline, as far as I know.

❝ ❝ make clear to the sponsor representatives in advance that they shall not try and influence in any way


❝ So shall CRO share their SOP and then sponsor shall make agenda?


The CRO should either make their SOPs available in advance (so that the monitor or auditor can prepare his visit) or at least make them available at the site during the visit. The monitor or auditor will decide what he wants to monitor or audit based on the sponsor's own SOPs and using his brain. But again, he should check compliance with regulations, guidelines and the lab's SOPs, but not interfere with the study conduct. Decisions remain with the study director, in accordance with GLP.

Regards
Ohlbe
dshah
★★  

India/United Kingdom,
2021-03-09 18:01
(1167 d 17:20 ago)

@ Ohlbe
Posting: # 22253
Views: 1,828
 

 Bioanalysis monitoring by sponsor

Greetings Ohlbe!

Thank you for your valuable suggestion.

Regards,
Dshah
UA Flag
Activity
 Admin contact
23,033 posts in 4,835 threads, 1,642 registered users;
39 visitors (0 registered, 39 guests [including 8 identified bots]).
Forum time: 12:22 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5